Thus, various studies have shown that the expression of CCL-2 is markedly increased in IPF and in various models of pulmonary fibrosis and that the neutralization of this chemokine or its receptor significantly attenuated fibrotic response [22,23]. Here, CCL2 is linked to idiopathic pulmonary fibrosis.